SCHEMBL22685142

SCHEMBL22685142

Cc1ccc2cc(Cc3ccc4cnccc4c3)ncc2c1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 2/20 0.42
CYP19A1 P11511 2/20 0.42
IMPDH2 P12268 2/20 0.40
TBXAS1 P24557 1/20 0.39
NOTUM Q6P988 1/20 0.39
ROCK1 Q13464 1/20 0.38
MAPT P10636 3/20 0.38
NR3C1 P04150 1/20 0.37
PRMT3 O60678 1/20 0.36
CSNK1D P48730 1/20 0.36
CSNK1E P49674 1/20 0.36
CLK1 P49759 1/20 0.36
DYRK1A Q13627 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2A6 P11509 1/20 0.36
AKT1 P31749 1/20 0.36
MELK Q14680 1/20 0.36
ROCK2 O75116 1/20 0.36
ABL1 P00519 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21363718 0.96 CYP19A1 (0.41) PDE10ACYP19A1IMPDH2TBXAS1NOTUM
SCHEMBL21363719 0.83 CYP2A6 (0.50) PDE10ACYP1A2CYP2A6
SCHEMBL23396668 0.80 PDE10A (0.43) PDE10ACYP19A1IMPDH2NOTUMROCK1
SCHEMBL18571835 0.79 PDE10A (0.42) PDE10ACYP19A1IMPDH2NOTUMMAPT
SCHEMBL30969150 0.78 CYP2A6 (0.59) CYP19A1IMPDH2NOTUMPRMT3CYP1A2
SCHEMBL2616771 0.78 CYP2A6 (0.59) CYP19A1IMPDH2NOTUMPRMT3CYP1A2
SCHEMBL21636294 0.77 PDE10A (0.43) PDE10ACYP19A1TBXAS1CYP1A2MELK
SCHEMBL22002109 0.77 PDE10A (0.50) PDE10ACYP19A1IMPDH2ROCK1
SCHEMBL18772842 0.76 KLKB1 (0.41) PDE10ACYP19A1TBXAS1ROCK1MAPT
SCHEMBL28189149 0.76 CYP19A1 (0.48) PDE10ACYP19A1IMPDH2TBXAS1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11318157-B2 6-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitors JANSSEN PHARMACEUTICA NV (BE) 2022-05-03 US disclosed
US-20200360416-A1 NOVEL 6-6 BICYCLIC AROMATIC RING SUBSTITUTED NUCLEOSIDE ANALOGUES FOR USE AS PRMT5 INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2020-11-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11318157-B2 6-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitors PRMT5, PRMT6, PRMT1 PDE10A 2051/4885CYP19A1 3969/4885IMPDH2 141/4885
US-20200360416-A1 NOVEL 6-6 BICYCLIC AROMATIC RING SUBSTITUTED NUCLEOSIDE ANALOGUES FOR USE AS PRMT5 INHIBITORS PRMT5, PRMT6, PRMT1 PDE10A 2247/4885CYP19A1 4340/4885IMPDH2 133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.